City of Hope’s Hematopoietic Cell Transplantation (HCT) program is one of the largest and most successful bone marrow and blood stem cell transplant centers in the world. As a pioneer in creating breakthrough treatments for all
and blood-related disorders, City of Hope’s Department of Hematology and Hematopoietic Cell Transplantation (HCT) is a world leader in setting standards for stem cell transplantation and in improving long-term outcomes for both children and adults.
Since City of Hope performed its first bone marrow transplant in 1976, more than 12,000 transplants have been completed for patients from virtually every state and around the world. City of Hope’s HCT program is dedicated to the traditional and newer uses of this procedure.
Specialists at City of Hope lead the field of stem cell transplantation with excellent outcomes.Transplant patients at City of Hope have ranged from younger than one to 79 years old.
City of Hope is renowned for developing innovative transplant regimens that have improved the cure rate for patients with:
City of Hope’s Hematopoietic Cell Transplantation Program is accredited by the Foundation for the Accreditation of Cellular Therapy (FACT), the gold standard of excellence for blood and bone marrow transplant programs in the United States.
Additionally, the Center for International Blood and Marrow Transplant Research Center has ranked City of Hope as an “over-performing” transplant center with better than expected survival outcomes, and City of Hope is the only U.S. transplant center with this recognition for nine consecutive years.
As one of a select number of institutes to attain the elite designation of
Comprehensive Cancer Center
by the National Cancer Institute, City of Hope is acknowledged as a leader in cancer research and treatment.
If you have been diagnosed with a hematologic cancer or are looking for a second opinion consultation about your treatment, find out more about
becoming a patient
or contact us at 800-826-HOPE.